|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Anemia In Chronic Kidney Disease - Pipeline Review, 2019 ... Iron sucrose darbepoetin alfa Epogen Molidustat Enarodustat Roxadustat EPO 018B PRS ... Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018 Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018 SUMMARY According to the recently published report 'Transmembrane Prolyl 4 Hydroxylase - Pipeline Review, H2 2018'; ... Global Anemia Drugs Market (Iron Deficiency, Sickle Cell, CKD, Aplastic Anemia): Analysis By Region, By Country (2016-2021) (By Type - Iron Deficiency Anemia, Chronic Kidney Disease related Anemia, Sickle Cell Anemia, Aplastic Anemia; By Region-North America, Europe, APAC, Latin America, MEA; By Country - USA, Canada, UK, Germany, India, Brazil, South Africa) Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global anemia drugs market on the basis ... Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H1 2018 Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H1 2018 SUMMARY Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - ... Transmembrane Prolyl 4 Hydroxylase - Pipeline Review, H2 2020 Transmembrane Prolyl 4 Hydroxylase - Pipeline Review, H2 2020 SUMMARY Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) pipeline Target constitutes close to 6 molecules. The latest report ... Transmembrane Prolyl 4 Hydroxylase - Drugs In Development, 2021 Transmembrane Prolyl 4 Hydroxylase - Drugs In Development, 2021 SUMMARY Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Prolyl 4 hydroxylases (P4H) are iron%li%and 2-oxoglutamate-dependent ... Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Transmembrane Prolyl 4 ... Veterinary Renal Disease Market Size, Share & Trends Analysis Report By Product Type (Diagnosis, Treatment), By Animal Type (Canine, Feline), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 ... U.S. FDA approval for Varenzin-CA1 (molidustat oral suspension), as the treatment to control ... |